Daniel E. Lopes de Menezes

In vivo Target Modulation and Biological Activity of CHIR-258, a Multitargeted Growth Factor Receptor Kinase Inhibitor, in Colon Cancer Models

Sang Hoon Lee, E. Samara, D. E. Lopes de Menezes, 2005, Clinical Cancer Research.

Recombinant Interleukin-2 Significantly Augments Activity of Rituximab in Human Tumor Xenograft Models of B-cell Non-Hodgkin Lymphoma

Yan Tang, J. Kunich, B. Jallal, 2007, Journal of immunotherapy.

CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia

Yan Tang, Sang H. Lee, Yan Tang, 2005, Clinical Cancer Research.

CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo

E. Moler, G. Schwartz, M. Embry, 2007, Clinical Cancer Research.